Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease? Despite decades of research ...

Not spending enough time in the two deep stages of sleep — slow-wave and rapid eye movement, or REM, sleep — may hasten the deterioration of parts of the brain associated with Alzheimer’s ...

A puzzling discovery has left doctors scratching their heads: The brain of an American woman with Down syndrome showed all the classic signs of Alzheimer’s disease, yet she remained symptom-free ...

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease, a neurodegenerative condition that affects ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.

Your loved one's treatments will depend on the type they have. Many older people fear that they have Alzheimer's disease because they can't find their eyeglasses or remember someone's name.

The 94-year-old died of heart disease and complications caused by Alzheimer’s disease, according to the New Mexico Office of the Medical Investigator. Alzheimer’s disease is a brain disorder ...

Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headaches if she tried a new drug from Eisai Co. that promised to ...

University of Wisconsin-Madison Professor Sterling Johnson leads one of the world's largest and longest-running studies of people at risk for Alzheimer's disease. His team aims to diagnose the ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...